Cargando…

Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience

Case series Patients: Female, 56-year-old • Female, 72-year-old • Female, 68-year-old Final Diagnosis: Dysarthria asscoaited with irinotecan infusion Symptoms: Slurred speach Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Irinotecan, a topoisomerase I inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbeddini, Ali, Hooda, Naushin, Gazarin, Mohamed, Webster, Penny, McMillan, Jackie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347036/ https://www.ncbi.nlm.nih.gov/pubmed/32594093 http://dx.doi.org/10.12659/AJCR.924058

Ejemplares similares

Irinotecan-Induced Dysarthria
por: Dressel, Albertine J., et al.
Publicado: (2012)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Pharmacy response to COVID-19: lessons learnt from Canada
por: Elbeddini, Ali, et al.
Publicado: (2020)

Fournier’s gangrene with dapagliflozin in a rural hospital: a case report
por: Elbeddini, Ali, et al.
Publicado: (2021)

Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources
por: Elbeddini, Ali, et al.
Publicado: (2021)

HYPOTHYROIDISM PRESENTING WITH DYSARTHRIA
por: El-Shafie, Kawther T.
Publicado: (2003)

A Case of Fournier’s Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus
por: Elbeddini, Ali, et al.
Publicado: (2020)

Pure dysarthria and dysarthria-facial paresis syndrome due to internal capsule and/or corona radiata infarction
por: Tanaka, Koji, et al.
Publicado: (2015)

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
por: Glassman, Danielle C., et al.
Publicado: (2018)

An Uncommon Cause of Dysarthria in an Elderly Gentleman
por: Noushad, Muhammad, et al.
Publicado: (2020)

Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021)

Communicative Participation in Dysarthria: Perspectives for Management
por: Page, Allyson D., et al.
Publicado: (2022)

Orofacial Muscle Strength across the Dysarthrias
por: Clark, Heather M., et al.
Publicado: (2022)

A 54‐year‐old with dysarthria
por: Huang, Derrick, et al.
Publicado: (2022)

Validation of the pediatric Radboud Dysarthria Assessment
por: Ruessink, Marieke, et al.
Publicado: (2022)

The Dysarthria Impact Profile: A Preliminary French Experience with Parkinson's Disease
por: Letanneux, Alban, et al.
Publicado: (2013)

Solitary sclerosis presenting as isolated spontaneous paroxysmal dysarthria
por: Xia, Yuanxuan, et al.
Publicado: (2019)

Rehabilitation of impaired speech function (dysarthria, dysglossia)
por: Schröter-Morasch, Heidrun, et al.
Publicado: (2005)

An adult man with progressive dysarthria, dysphagia and disequilibrium
por: Rohani, Mohammad
Publicado: (2012)

Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem
por: Poujois, Aurélia, et al.
Publicado: (2017)

Constrained-Induced Dysarthria Therapy: Case Report
por: Roggeman, Stijn, et al.
Publicado: (2019)

Development of the Korea Dysarthria Test Following Stroke
por: Kim, Hyo Jong, et al.
Publicado: (2022)

Dysarthria in hereditary spastic paraplegia type 4
por: Jacinto-Scudeiro, Lais Alves, et al.
Publicado: (2022)

Acute Isolated Dysarthria Is Associated with a High Risk of Stroke
por: Beliavsky, Alina, et al.
Publicado: (2014)

What is the Etiology of Dysarthria and Ataxia in a Woman With Cancer?
por: Anastasia, Paula J.
Publicado: (2014)

Speech Signal Analysis and Pattern Recognition in Diagnosis of Dysarthria
por: Thoppil, Minu George, et al.
Publicado: (2017)

A Case of Frontotemporal Lobar Degeneration with Progressive Dysarthria
por: Ihori, Nami, et al.
Publicado: (2006)

From Dysarthria to Tetanus: Case Report and Diagnostic Considerations
por: Bilreiro, Mariana, et al.
Publicado: (2022)

Dysarthria-Facial Paresis and Rostral Pontine Ischemic Stroke
por: Miyawaki, Edison K., et al.
Publicado: (2022)

Hypokinetic Dysarthria in Parkinson’s Disease: A Narrative Review
por: Atalar, Merve Sapmaz, et al.
Publicado: (2023)

Possible Association of Tremors and Dysarthria with Losartan Use: A Case Report
por: Fishman, Troy J, et al.
Publicado: (2019)

Korean language specific dysarthria associated with idiopathic peripheral facial palsy
por: Lee, Dong-Woo, et al.
Publicado: (2020)

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2023)

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
por: Mesti, Tanja, et al.
Publicado: (2015)

Dysphagia and Dysarthria in Children with Neuromuscular Diseases, a Prevalence Study
por: Kooi-van Es, Mieke, et al.
Publicado: (2020)

Effect of boost articulation therapy (BArT) on intelligibility in adults with dysarthria
por: Mendoza Ramos, Viviana, et al.
Publicado: (2021)

The Reliability and Validity of Speech-Language Pathologists’ Estimations of Intelligibility in Dysarthria
por: Hirsch, Micah E., et al.
Publicado: (2022)

Case 6: A 27-Year-Old Woman With Dysarthria
por: Lee, Donghan, et al.
Publicado: (2022)

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
por: Mahdy, Marwa S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q69tn5k958jciat7p407ep2h6h